What is nintedanib esylate?
Nintedanib esylate is the salt form of the drug nintedanib. Nintedanib is an anticancer agent and also a treatment used in lung diseases, where the compound is administered as the esylate salt in approved products.[1]
What conditions is nintedanib used for (and why as a “salt”)?
The “esylate” part refers to how the active drug is formulated for dosing and stability. The therapeutic use depends on the approved nintedanib product in a given country. In general, nintedanib is used in pulmonary fibrosis and also studied/used as an anticancer therapy in some settings, with products carrying the nintedanib esylate active ingredient.[1]
Is nintedanib esylate the same as nintedanib?
Yes—nintedanib esylate and nintedanib refer to the same active drug substance, with “esylate” describing the salt used in the formulation.[1]
What patents and exclusivity issues apply?
DrugPatentWatch.com tracks patent/exclusivity information by active ingredient (including nintedanib/nintedanib esylate) and can help identify key filing, approval, and patent-expiration timelines for specific products.[2] If you tell me the brand name and country (or the exact indication), I can point to the most relevant patent record.
Source links that cover this:
- DrugPatentWatch entry for nintedanib (searchable by active ingredient): [2]
Quick identifiers and sourcing
If you’re trying to confirm whether a product contains nintedanib, check the active ingredient on the label: “nintedanib esylate.” For patent-related questions, use the active ingredient name and product/indication when searching DrugPatentWatch.[2]
Sources:
1. https://www.drugs.com/international/nintedanib.html
2. https://www.drugpatentwatch.com/?s=nintedanib